Related Experiment Videos
Phenytoin-induced linear IgA bullous disease
J M Acostamadiedo1, C Perniciaro, R S Rogers
1Department of Internal Medicine, Mayo Clinic Jacksonville, Florida 32224, USA.
Journal of the American Academy of Dermatology
|March 5, 1998
Summary
Drug-induced linear IgA bullous disease, often linked to vancomycin, can also be triggered by other drugs. This case highlights phenytoin as a potential cause of this rare skin condition.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Drug-induced skin reactions represent a significant clinical challenge.
- Linear IgA bullous disease (LABD) is a rare autoimmune blistering disorder.
Observation:
- A 78-year-old male patient presented with clinical features suggestive of LABD.
- The patient had a history of recent treatment with phenytoin.
Findings:
- The patient was diagnosed with drug-induced linear IgA bullous disease.
- Phenytoin was identified as the likely causative agent for the patient's condition.
Implications:
- This case expands the spectrum of medications known to induce LABD.
- Clinicians should consider phenytoin in the differential diagnosis of drug-induced bullous eruptions.
- Early identification and withdrawal of the offending drug are crucial for patient management.